Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Coronary thrombolysis: progress and promise.

B E Sobel

    Journal of Cardiovascular Pharmacology
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Thrombolysis treatment for coronary heart disease is crucial and requires prompt initiation. Newer, safer thrombolytic agents offer future promise for treating acute myocardial infarction effectively.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Biomarkers, surrogates, and evaluation of therapeutic agents: a proposed solution.

    Coronary artery disease·1999
    Same author

    The potential influence of insulin and plasminogen activator inhibitor type 1 on the formation of vulnerable atherosclerotic plaques associated with type 2 diabetes.

    Proceedings of the Association of American Physicians·1999
    Same author

    Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications.

    Thrombosis research·1999
    Same author

    Insulin resistance and thrombosis: a cardiologist's view.

    The American journal of cardiology·1999
    Same author

    TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes.

    The American journal of physiology·1999
    Same author

    Cardiovascular consequences of polycystic ovary syndrome.

    Endocrinology and metabolism clinics of North America·1999

    Area of Science:

    • Cardiology
    • Thrombosis Research
    • Pharmacology

    Background:

    • Thrombolysis for coronary heart disease is a recent but rapidly advancing field.
    • Acute coronary thrombosis necessitates immediate thrombolytic intervention.
    • Existing treatments highlight the need for improved therapeutic agents.

    Purpose of the Study:

    • To review the therapeutic history and current interest in thrombolysis for coronary heart disease.
    • To emphasize the critical timing for initiating thrombolysis in acute coronary thrombosis.
    • To explore the potential of novel thrombolytic agents in managing acute myocardial infarction.

    Main Methods:

    • Review of studies on the evolution of acute coronary thrombosis.
    • Analysis of the necessity for early thrombolysis.

    Related Experiment Videos

  • Evaluation of characteristics of developing thrombolytic agents.

    • Main Results:

    • Early initiation of thrombolysis is vital for acute coronary thrombosis.
    • Newer agents are being developed with improved safety and efficacy profiles.
    • Parenteral administration of these agents is key for rapid treatment.

    Conclusions:

    • Prompt thrombolysis is essential in acute coronary heart disease.
    • Future treatments for acute myocardial infarction will likely involve advanced thrombolytic drugs.
    • Low toxicity and non-antigenic properties are key features of promising new agents.